DK3442657T3 - Fremgangsmåde til evaluering af artikulære ledterapi - Google Patents
Fremgangsmåde til evaluering af artikulære ledterapi Download PDFInfo
- Publication number
- DK3442657T3 DK3442657T3 DK16898834.3T DK16898834T DK3442657T3 DK 3442657 T3 DK3442657 T3 DK 3442657T3 DK 16898834 T DK16898834 T DK 16898834T DK 3442657 T3 DK3442657 T3 DK 3442657T3
- Authority
- DK
- Denmark
- Prior art keywords
- evaluation
- procedure
- articular joint
- joint therapy
- therapy
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/105—Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2016/027789 WO2017180150A1 (en) | 2016-04-15 | 2016-04-15 | Method for evaluating articular joint therapeutics |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3442657T3 true DK3442657T3 (da) | 2022-10-03 |
Family
ID=60042860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16898834.3T DK3442657T3 (da) | 2016-04-15 | 2016-04-15 | Fremgangsmåde til evaluering af artikulære ledterapi |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP3442657B1 (da) |
JP (1) | JP6768922B2 (da) |
AU (1) | AU2016402361B2 (da) |
BR (1) | BR112018071091A2 (da) |
CA (1) | CA3020688C (da) |
DK (1) | DK3442657T3 (da) |
ES (1) | ES2928171T3 (da) |
HU (1) | HUE060598T2 (da) |
PL (1) | PL3442657T3 (da) |
PT (1) | PT3442657T (da) |
RS (1) | RS63770B1 (da) |
RU (1) | RU2714312C1 (da) |
SI (1) | SI3442657T1 (da) |
WO (1) | WO2017180150A1 (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2953017T3 (es) * | 2018-04-03 | 2023-11-07 | Sanofi Sa | Dispositivo de tira de inmunoensayo de flujo lateral |
JP7421744B2 (ja) * | 2019-08-28 | 2024-01-25 | 学校法人順天堂 | 変形性関節症の診断 |
KR102288646B1 (ko) * | 2020-01-30 | 2021-08-11 | 충남대학교산학협력단 | 반려동물 골관절염 진단용 당사슬 바이오마커 및 이를 이용한 반려동물 골관절염 진단방법 |
KR102384149B1 (ko) * | 2020-09-09 | 2022-04-08 | 아주대학교산학협력단 | 턱관절 골관절염 진단 또는 예후 예측용 바이오마커 조성물 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050221383A1 (en) * | 2003-08-08 | 2005-10-06 | Choong-Chin Liew | Osteoarthritis biomarkers and uses thereof |
US20050124071A1 (en) | 2003-09-30 | 2005-06-09 | Kraus Virginia B. | Methods and compositions for diagnosing musculoskeletal, arthritic and joint disorders by biomarker dating |
WO2005036446A2 (en) * | 2003-10-07 | 2005-04-21 | Entelos, Inc. | Simulating patient-specific outcomes |
WO2007089303A2 (en) * | 2005-11-01 | 2007-08-09 | Abbott Biotechnology Ltd. | Methods and compositions for diagnosing ankylosing spondylitis using biomarkers |
US20090299769A1 (en) * | 2008-05-29 | 2009-12-03 | Nordic Bioscience Imaging A/S | Prognostic osteoarthritis biomarkers |
CA2790684C (en) * | 2010-02-22 | 2019-02-12 | Duke University | Biomarkers of musculoskeletal disease |
US8428045B2 (en) * | 2010-03-16 | 2013-04-23 | Harman International Industries, Incorporated | Media clock recovery |
-
2016
- 2016-04-15 EP EP16898834.3A patent/EP3442657B1/en active Active
- 2016-04-15 CA CA3020688A patent/CA3020688C/en active Active
- 2016-04-15 BR BR112018071091A patent/BR112018071091A2/pt not_active Application Discontinuation
- 2016-04-15 RU RU2018139984A patent/RU2714312C1/ru active
- 2016-04-15 RS RS20220989A patent/RS63770B1/sr unknown
- 2016-04-15 SI SI201631619T patent/SI3442657T1/sl unknown
- 2016-04-15 PL PL16898834.3T patent/PL3442657T3/pl unknown
- 2016-04-15 ES ES16898834T patent/ES2928171T3/es active Active
- 2016-04-15 JP JP2019506342A patent/JP6768922B2/ja active Active
- 2016-04-15 WO PCT/US2016/027789 patent/WO2017180150A1/en active Application Filing
- 2016-04-15 AU AU2016402361A patent/AU2016402361B2/en active Active
- 2016-04-15 PT PT168988343T patent/PT3442657T/pt unknown
- 2016-04-15 DK DK16898834.3T patent/DK3442657T3/da active
- 2016-04-15 HU HUE16898834A patent/HUE060598T2/hu unknown
Also Published As
Publication number | Publication date |
---|---|
AU2016402361A1 (en) | 2018-11-01 |
JP6768922B2 (ja) | 2020-10-14 |
RU2714312C1 (ru) | 2020-02-14 |
CA3020688A1 (en) | 2017-10-19 |
RS63770B1 (sr) | 2022-12-30 |
CA3020688C (en) | 2022-07-12 |
AU2016402361B2 (en) | 2022-08-11 |
EP3442657B1 (en) | 2022-07-27 |
EP3442657A1 (en) | 2019-02-20 |
JP2019517007A (ja) | 2019-06-20 |
BR112018071091A2 (pt) | 2019-01-29 |
ES2928171T3 (es) | 2022-11-15 |
PT3442657T (pt) | 2022-10-13 |
SI3442657T1 (sl) | 2023-01-31 |
WO2017180150A1 (en) | 2017-10-19 |
EP3442657A4 (en) | 2019-10-16 |
HUE060598T2 (hu) | 2023-03-28 |
PL3442657T3 (pl) | 2023-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3331915T3 (da) | Immun-checkpoint-inhibitorer til anvendelse til behandling af blodbårne cancere | |
DK3286181T3 (da) | Pyrazolforbindelser og fremgangsmåde til fremstilling og anvendelse af forbindelserne | |
DK3192902T3 (da) | Fremgangsmåde til fremstilling af graphenholdige viscosefibre | |
DK3189082T3 (da) | Anti-pd-l1-konjugater til behandling af tumorer | |
DK3096741T3 (da) | Fremgangsmåde til fremstillingen af hybridosomer | |
DK3160956T3 (da) | Inhibitorer af lysin-specifik demethylase-1 | |
DK3143025T3 (da) | Forbindelser til behandling af spinal muskelatrofi | |
DK3294720T3 (da) | Fremgangsmåde til fremstilling af terpinolenepoxid | |
DK3174858T3 (da) | Fremgangsmåde til fremstilling af pyrazoler | |
DK3511319T3 (da) | Hæmmere af lysinspecifik demethylase-1 | |
DK3668851T3 (da) | Fremgangsmåde til fremstilling af thiocarbonater | |
DK3325443T3 (da) | Fremgangsmåde til fremstilling af pridopidin | |
DK3317400T3 (da) | Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter | |
DK3240612T3 (da) | Fremgangsmåder til behandling af nethindesygdomme | |
DK3362066T3 (da) | Kombinationsterapi til behandling af maligniteter | |
DK3390390T3 (da) | Bipyrazolylderivater egnede til behandling af autoimmunsygdomme | |
DK3331879T3 (da) | Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne | |
DK3166628T3 (da) | Terapeutisk anvendelse af knoglemorfogenetiske proteiner | |
DK3280408T3 (da) | Fremgangsmåde til fremstilling af dicycloplatin | |
DK3363148T3 (da) | Afdækning af krypteringsanvendelse | |
FI20155191A (fi) | Nivel | |
DK3347342T3 (da) | Fremgangsmåde til fremstilling af biguanidin-salte og s-triaziner | |
DK3297619T3 (da) | Terapeutiske anvendelser af L-4-chlorkynurenin | |
DK3286317T3 (da) | Dynamin 2-inhibitor til behandlingen af duchennes muskeldystrofi | |
DK3488443T3 (da) | Udvælgelse af neoepitoper som sygdomsspecifikke mål for terapi med øget virkning |